AU6726400A - Screening method - Google Patents

Screening method

Info

Publication number
AU6726400A
AU6726400A AU67264/00A AU6726400A AU6726400A AU 6726400 A AU6726400 A AU 6726400A AU 67264/00 A AU67264/00 A AU 67264/00A AU 6726400 A AU6726400 A AU 6726400A AU 6726400 A AU6726400 A AU 6726400A
Authority
AU
Australia
Prior art keywords
screening method
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67264/00A
Inventor
Shuji Hinuma
Masaki Hosoya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU6726400A publication Critical patent/AU6726400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU67264/00A 1999-08-24 2000-08-23 Screening method Abandoned AU6726400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/236597 1999-08-24
JP23659799 1999-08-24
PCT/JP2000/005639 WO2001014883A1 (en) 1999-08-24 2000-08-23 Screening method

Publications (1)

Publication Number Publication Date
AU6726400A true AU6726400A (en) 2001-03-19

Family

ID=17003012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67264/00A Abandoned AU6726400A (en) 1999-08-24 2000-08-23 Screening method

Country Status (2)

Country Link
AU (1) AU6726400A (en)
WO (1) WO2001014883A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2482915A1 (en) * 2002-04-16 2003-10-23 Kyowa Hakko Kogyo Co., Ltd. Endocrine cell lines and method of using the same
KR101601865B1 (en) * 2008-11-28 2016-03-09 (주)아모레퍼시픽 Method for screening harmful responses of skin by pollen house dust mite or yellow sand dust and the composition for skin external application controlling the responses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0970289A (en) * 1995-06-27 1997-03-18 Takeda Chem Ind Ltd Human crf2 recepter protein, its production and use
JPH10127289A (en) * 1996-10-29 1998-05-19 Takeda Chem Ind Ltd New g protein conjugate type receptor protein and its dna
JP3902286B2 (en) * 1997-05-15 2007-04-04 塩野義製薬株式会社 Method for screening agonist or antagonist of binding between Doc2α and Munc13
JPH11127872A (en) * 1997-08-11 1999-05-18 Japan Tobacco Inc New intranuclear receptor protein, gene and its use

Also Published As

Publication number Publication date
WO2001014883A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
AU5312198A (en) Screening method
AU1854901A (en) Novel method
GB0009358D0 (en) Compound screening method
EP1469316A2 (en) Screening method
AU7433900A (en) Screening methods
AU2308900A (en) Analysis method
AU1553101A (en) Screening method
AU6429000A (en) Screening method
GB9923075D0 (en) Screening method
AU3984700A (en) Compound screening methods
GB2359360B (en) Compound screening method
AU2872501A (en) Screening method
AU2310900A (en) Screening methods
AU3686800A (en) Screening apparatus
AU6726400A (en) Screening method
GB9930255D0 (en) Screening method
AU5552200A (en) Method
AU2000224577A1 (en) Screening method
AU4585100A (en) Method
AU2001288116A1 (en) Screening method
AU2002220868A1 (en) Screening method
AU1164401A (en) Method
AUPP249898A0 (en) Screening method I
GB9915225D0 (en) Screening method
GB9915226D0 (en) Screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase